Multi-antigen DNA vaccine delivered by polyethylenimine and Salmonella enterica in neuroblastoma mouse model
Author:
Funder
Ministry of Health
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology,Immunology,Immunology and Allergy
Link
https://link.springer.com/content/pdf/10.1007/s00262-020-02652-2.pdf
Reference43 articles.
1. Brodeur GM (2003) Neuroblastoma: biological insights into a clinical enigma. Nat Rev Cancer 3(3):203–216. https://doi.org/10.1038/nrc1014
2. Cheung NKV, Dyer MA (2013) Neuroblastoma: developmental biology, cancer genomics and immunotherapy. Nat Rev Cancer 13(6):397–411. https://doi.org/10.1038/nrc3526
3. Smith V, Foster J (2018) High-risk neuroblastoma treatment review. Children 5(9):114. https://doi.org/10.3390/children5090114
4. Meleshko AN, Petrovskaya NA, Savelyeva N, Vashkevich KP, Doronina SN, Sachivko NV (2017) Phase I clinical trial of idiotypic DNA vaccine administered as a complex with polyethylenimine to patients with B-cell lymphoma. Hum Vaccines Immunother 13(6):1398–1403. https://doi.org/10.1080/21645515.2017.1285477
5. Ponomarenko DM, Klimova ID, Chapygina YA, Dvornichenko VV, Zhukova NV, Orlova RV, Shneider AM (2017) Safety and efficacy of p62 DNA vaccine ELENAGEN in a first-in-human trial in patients with advanced solid tumors. Oncotarget 8(32):53730–53739. https://doi.org/10.18632/oncotarget.16574
Cited by 16 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Microbial messengers: nucleic acid delivery by bacteria;Trends in Biotechnology;2024-08
2. Pilot clinical trial of DNA vaccination against neuroblastoma: study design and preliminary results;Russian Journal of Pediatric Hematology and Oncology;2024-01-17
3. Advances in anti-tumor based on various anaerobic bacteria and their derivatives as drug vehicles;Frontiers in Bioengineering and Biotechnology;2023-10-03
4. Polyethylenimine (PEI) in gene therapy: Current status and clinical applications;Journal of Controlled Release;2023-10
5. Advancement in Polymer-based Carrier for DNA Vaccine;Current Pharmaceutical Design;2023-07
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3